Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slack

Showing results (431-440 of 472) with videos related to

Pageof 48
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>Eleni Anastasiadou, Anita G Seto, Xuan Beatty, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2024
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, et al.
Nature Communications|October 23, 2024
sChemNET: a deep learning framework for predicting small molecules targeting microRNA functionDiego Galeano, Imrat, Jeffrey Haltom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSylvie Belleville, Nicole D Anderson, John R Best, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Journal of Medicinal Chemistry|October 17, 2024
Core Modifications of GSK3335103 toward Orally Bioavailable α<sub>v</sub>β<sub>6</sub> Inhibitors with Improved Synthetic TractabilityHeather F Hryczanek, John Barrett, Tim N Barrett, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
AIDS (London, England)|August 19, 2022
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West AfricaDouglas L Fink, David A Oladele, Abigail J Slack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2020
Preclinical evaluation of [<sup>18</sup>F]FB-A20FMDV2 as a selective marker for measuring α<sub>V</sub>β<sub>6</sub> integrin occupancy using positron emission tomography in rodent lungMayca Onega, Christine A Parker, Christopher Coello, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Pageof 48

Showing results (431-440 of 472) with videos related to

Sort By:
Pageof 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>Eleni Anastasiadou, Anita G Seto, Xuan Beatty, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2024
Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1)Vassilios Aslanis, Khalid Abd-Elaziz, Robert J Slack, et al.
Nature Communications|October 23, 2024
sChemNET: a deep learning framework for predicting small molecules targeting microRNA functionDiego Galeano, Imrat, Jeffrey Haltom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSylvie Belleville, Nicole D Anderson, John R Best, et al.
Journal of Medicinal Chemistry|May 28, 2024
Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung CancerFredrik R Zetterberg, Kristoffer Peterson, Ulf J Nilsson, et al.
Journal of Medicinal Chemistry|October 17, 2024
Core Modifications of GSK3335103 toward Orally Bioavailable α<sub>v</sub>β<sub>6</sub> Inhibitors with Improved Synthetic TractabilityHeather F Hryczanek, John Barrett, Tim N Barrett, et al.
Bone Marrow Transplantation|August 6, 2003
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patientsT Hahn, C Rondeau, A Shaukat, et al.
AIDS (London, England)|August 19, 2022
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West AfricaDouglas L Fink, David A Oladele, Abigail J Slack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2020
Preclinical evaluation of [<sup>18</sup>F]FB-A20FMDV2 as a selective marker for measuring α<sub>V</sub>β<sub>6</sub> integrin occupancy using positron emission tomography in rodent lungMayca Onega, Christine A Parker, Christopher Coello, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Pageof 48